Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding
about
Cryo-electron tomographic structure of an immunodeficiency virus envelope complex in situStructural mechanism of trimeric HIV-1 envelope glycoprotein activationCharacterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81.HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapseEnergetics of the HIV gp120-CD4 binding reactionSpontaneous mutations in the env gene of the human immunodeficiency virus type 1 NDK isolate are associated with a CD4-independent entry phenotype.Comparative cellular processing of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp160 by the mammalian subtilisin/kexin-like convertasesMultimeric CD4 binding exhibited by human and simian immunodeficiency virus envelope protein dimersPathogenesis of human immunodeficiency virus infectionAccess of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41Anti-HIV-1 activity of cellulose acetate phthalate: synergy with soluble CD4 and induction of "dead-end" gp41 six-helix bundles.Role of CD4 epitopes outside the gp120-binding site during entry of human immunodeficiency virus type 1A rat CD4 mutant containing the gp120-binding site mediates human immunodeficiency virus type 1 infectionStructures of the CCR5 N Terminus and of a Tyrosine-Sulfated Antibody with HIV-1 gp120 and CD4Molecular architecture of native HIV-1 gp120 trimersStructure-Based Design, Synthesis, and Characterization of Dual Hotspot Small-Molecule HIV-1 Entry InhibitorsBioinformatic analysis of HIV-1 entry and pathogenesis.Atomic structure of a thermostable subdomain of HIV-1 gp41Internal dynamics of the homotrimeric HIV-1 viral coat protein gp41 on multiple time scalesPeptide ligands to human immunodeficiency virus type 1 gp120 identified from phage display librariesSensitivity to a nonpeptidic compound (RPR103611) blocking human immunodeficiency virus type 1 Env-mediated fusion depends on sequence and accessibility of the gp41 loop regionRole of human immunodeficiency virus (HIV) type 1 envelope in the anti-HIV activity of the betulinic acid derivative IC9564Inhibition of human immunodeficiency virus infection by agents that interfere with thiol-disulfide interchange upon virus-receptor interactionAnti-human immunodeficiency virus type 1 activity of an oligocationic compound mediated via gp120 V3 interactionsDeterminants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides.Virus neutralisation: new insights from kinetic neutralisation curvesAnalysis of physicochemical and structural properties determining HIV-1 coreceptor usageMutations in the leucine zipper of the human immunodeficiency virus type 1 transmembrane glycoprotein affect fusion and infectivityA molecular clasp in the human immunodeficiency virus (HIV) type 1 TM protein determines the anti-HIV activity of gp41 derivatives: implication for viral fusionCharacterization of neutralizing monoclonal antibodies to linear and conformation-dependent epitopes within the first and second variable domains of human immunodeficiency virus type 1 gp120Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoproteinThe ectodomain of HIV-1 env subunit gp41 forms a soluble, alpha-helical, rod-like oligomer in the absence of gp120 and the N-terminal fusion peptideCD4-Induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: consequences for virus entry and neutralization.Structure of an unliganded simian immunodeficiency virus gp120 coreStructure of a V3-containing HIV-1 gp120 coreEmergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.The influence of N-linked glycans on the molecular dynamics of the HIV-1 gp120 V3 loop.Structure-based design, synthesis and validation of CD4-mimetic small molecule inhibitors of HIV-1 entry: conversion of a viral entry agonist to an antagonist.The Patterns of Coevolution in Clade B HIV Envelope's N-Glycosylation Sites
P2860
Q21090535-59782AFC-D442-47EA-8B92-712340AE1BE3Q21131394-F27EAE70-F5DA-44E3-8C88-8A9E4A55C08CQ22010245-3F118919-1F3F-4C90-8C80-08A0F745875CQ22242967-50355A2B-0FE6-4E9D-B826-E4305CE7F0FDQ22254716-A04873C6-6744-42DC-810F-292002207ED7Q24523003-A93E89D7-D256-4BB0-B630-492ACB3A1A30Q24534205-FB9640C0-ACE7-470D-AE60-61684B7D4EDBQ24630280-81F3461A-FE8B-47B3-AA66-07BDB1B12444Q24634681-A68F258E-7DAF-4210-8892-4FFD097BC02AQ24645530-77C14A0E-32E7-41C6-A46D-6699F8BEBF4FQ24675546-D6D34C3C-BBAF-483B-B60A-55E6880264E2Q24791794-3C6419E8-6EAF-4EE1-943A-A6FC7F472A59Q27480782-4614C696-8151-4486-8114-D3D391E1AAC0Q27485098-F58EFD05-1C83-47F3-8C69-1A2271E80BF0Q27648643-277C5A48-A843-4160-BDC8-99A417CA8750Q27651385-61981337-D9CA-4246-8329-E69C51A6B125Q27678493-14211457-1783-4CD1-8B3B-277CDD0324C4Q27693321-0DBB72E5-F644-48CE-BE4C-C39BD05AD9EDQ27746904-79C63A11-2FFB-4237-A72C-494C29EB854DQ28286428-9E32A068-51CC-49E0-93A0-A8F4DED44614Q28343374-5F0EFDE6-D3DB-476A-B15C-9B6CE433B452Q28343901-BF17F159-8FE8-4C69-B7E1-C0B053E79429Q28345233-A3644376-CF4F-4009-9A95-A9EA18D35592Q28369689-3D4B15D2-97B7-4C7A-B8CE-749BC9612DA9Q28378840-F4A02FA1-F914-4996-8802-457E670B28E9Q28379310-63FD1BF6-D46B-4E09-B4F7-9529644B87B9Q28487427-A9D8D992-930B-4849-AF01-91573F42A125Q28488611-87DE99D2-0213-4CFB-9DAF-27EB10B24EB3Q28646740-55CCC147-7B1B-4D0C-8261-FFC53D01778DQ28646828-F9786558-2EB6-4869-A059-5FF584715E3DQ28646835-1D821B84-DA58-4718-AD91-9B25FC186948Q28646850-0611A90D-B415-46B0-B9FB-A9A689C70427Q28646857-D023EB11-B841-4305-B3C5-78B2AB27F1F1Q28646881-CC99CBC4-133E-4A73-B758-3284A6000FF0Q29616089-CFA847F7-711E-44F7-9F8A-F478413EB124Q29619014-1FD4A1D3-9001-4468-9887-45744CBA157FQ29619254-DB0448B5-18A0-4D25-8BC7-2DC6641B5097Q30356350-FF81BE2F-EB2E-4708-9975-175E7F67DAB1Q30358736-F3CFF51E-2842-4326-A246-714BA7470BAAQ30376065-CAEE5D6D-5E16-4395-AA5A-E06CADECC358
P2860
Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Conformational changes induced ...... protein by soluble CD4 binding
@ast
Conformational changes induced ...... protein by soluble CD4 binding
@en
type
label
Conformational changes induced ...... protein by soluble CD4 binding
@ast
Conformational changes induced ...... protein by soluble CD4 binding
@en
prefLabel
Conformational changes induced ...... protein by soluble CD4 binding
@ast
Conformational changes induced ...... protein by soluble CD4 binding
@en
P2860
P356
P1476
Conformational changes induced ...... protein by soluble CD4 binding
@en
P2093
Sattentau QJ
P2860
P304
P356
10.1084/JEM.174.2.407
P407
P577
1991-08-01T00:00:00Z